
1. sci rep. 2017 aug 22;7(1):9129. doi: 10.1038/s41598-017-09684-2.

immunological memory blood-stage malaria infection controlled the
histamine releasing factor (hrf) parasite.

demarta-gatsi c(1)(2)(3), peronet r(1)(2)(3), smith l(1)(2)(3), thiberge s(4),
ménard r(4), mécheri s(5)(6)(7).

author information: 
(1)institut pasteur, unité de biologie des interactions hôte parasites, paris,
f-75015, france.
(2)cnrs erl9195, paris, f-75015, france.
(3)inserm u1201, paris, f-75015, france.
(4)institut pasteur, unité de biologie et génétique du paludisme, f-75015, paris,
france.
(5)institut pasteur, unité de biologie des interactions hôte parasites, paris,
f-75015, france. smecheri@pasteur.fr.
(6)cnrs erl9195, paris, f-75015, france. smecheri@pasteur.fr.
(7)inserm u1201, paris, f-75015, france. smecheri@pasteur.fr.

while subunit malaria vaccines provide limited efficacy,
pre-erythrocytic erythrocytic genetically attenuated parasites (gap) have
been shown confer complete sterilizing immunity. recently generated a
plasmodium berghei (pbnk65) parasite lacks secreted factor, histamine 
releasing factor (hrf) (pbnk65 hrfδ), induces infected mice a
self-resolving blood stage infection accompanied long lasting immunity.
here, explore immunological mechanisms underlying anti-parasite
protective properties mutant pbnk65 hrfδ demonstrate addition 
to up-regulation il-6 production, cd4+ cd8+ effector lymphocytes 
are indispensable clearance malaria infection. maintenance t
cell-associated protection associated reduction cd4+pd-1+ and
cd8+pd-1+ cell numbers. higher number central effector memory b cells 
in mutant-infected mice also plays pivotal role protection. importantly, 
also demonstrate prior infection wt parasites followed drug cure
does prevent induction pbnk65 hrfδ-induced protection, suggesting that
such protection humans may efficient even individuals been
infected repeatedly received antimalarial drugs.

doi: 10.1038/s41598-017-09684-2 
pmcid: pmc5567273
pmid: 28831137  [indexed medline]

